These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 28450461)

  • 21. Genetic mapping found major QTLs for antibody-induced glomerulonephritis in WKY rats.
    Kose H; Sado Y; Yamada T; Matsumoto K
    Exp Anim; 2009 Apr; 58(2):193-8. PubMed ID: 19448344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic effects of ulinastatin on experimental crescentic glomerulonephritis in rats.
    Koizumi R; Kanai H; Maezawa A; Kanda T; Nojima Y; Naruse T
    Nephron; 2000 Apr; 84(4):347-53. PubMed ID: 10754412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TNF-alpha up-regulates renal MIF expression in rat crescentic glomerulonephritis.
    Lan HY; Yang N; Metz C; Mu W; Song Q; Nikolic-Paterson DJ; Bacher M; Bucala R; Atkins RC
    Mol Med; 1997 Feb; 3(2):136-44. PubMed ID: 9085256
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Genetic linkage mapping of 11 novel DNA markers and the ceruloplasmin (Cp) gene on rat chromosome 2.
    Shepel LA; Fleming RE; Haag JD; Brasic GM; Gheen ME; Simon JS; Gould MN
    Cytogenet Cell Genet; 1997; 79(3-4):176-8. PubMed ID: 9605844
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unique regulatory properties of mesangial cells are genetically determined in the rat.
    Lai PC; Chiu LY; Srivastava P; Trento C; Dazzi F; Petretto E; Cook HT; Behmoaras J
    PLoS One; 2014; 9(10):e111452. PubMed ID: 25343449
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment with a cyclin-dependent kinase inhibitor, seliciclib, is effective in reducing glomerular macrophage numbers and the severity of established experimental glomerulonephritis.
    Sheryanna AM; Smith J; Bhangal G; Barnett A; McClue S; Tam FW; Cook T; Pusey CD
    Nephrology (Carlton); 2011 May; 16(4):410-6. PubMed ID: 21518118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antibodies to intercellular adhesion molecule 1/lymphocyte function-associated antigen 1 prevent crescent formation in rat autoimmune glomerulonephritis.
    Nishikawa K; Guo YJ; Miyasaka M; Tamatani T; Collins AB; Sy MS; McCluskey RT; Andres G
    J Exp Med; 1993 Mar; 177(3):667-77. PubMed ID: 8094735
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Therapeutic effects of prostacyclin analog on crescentic glomerulonephritis of rat.
    Kushiro M; Shikata K; Sugimoto H; Shikata Y; Miyatake N; Wada J; Miyasaka M; Makino H
    Kidney Int; 1998 May; 53(5):1314-20. PubMed ID: 9573547
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Live Imaging of Monocyte Subsets in Immune Complex-Mediated Glomerulonephritis Reveals Distinct Phenotypes and Effector Functions.
    Turner-Stokes T; Garcia Diaz A; Pinheiro D; Prendecki M; McAdoo SP; Roufosse C; Cook HT; Pusey CD; Woollard KJ
    J Am Soc Nephrol; 2020 Nov; 31(11):2523-2542. PubMed ID: 32868399
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Local macrophage proliferation in the pathogenesis of glomerular crescent formation in rat anti-glomerular basement membrane (GBM) glomerulonephritis.
    Lan HY; Nikolic-Paterson DJ; Mu W; Atkins RC
    Clin Exp Immunol; 1997 Nov; 110(2):233-40. PubMed ID: 9367407
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Statin attenuates experimental anti-glomerular basement membrane glomerulonephritis together with the augmentation of alternatively activated macrophages.
    Fujita E; Shimizu A; Masuda Y; Kuwahara N; Arai T; Nagasaka S; Aki K; Mii A; Natori Y; Iino Y; Katayama Y; Fukuda Y
    Am J Pathol; 2010 Sep; 177(3):1143-54. PubMed ID: 20696778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antibody blockade of TNF-alpha reduces inflammation and scarring in experimental crescentic glomerulonephritis.
    Khan SB; Cook HT; Bhangal G; Smith J; Tam FW; Pusey CD
    Kidney Int; 2005 May; 67(5):1812-20. PubMed ID: 15840028
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Regulation of macrophage ceruloplasmin gene expression: one paradigm of 3'-UTR-mediated translational control.
    Mazumder B; Sampath P; Fox PL
    Mol Cells; 2005 Oct; 20(2):167-72. PubMed ID: 16267389
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Macrophage apoptosis in rat crescentic glomerulonephritis.
    Lan HY; Mitsuhashi H; Ng YY; Nikolic-Paterson DJ; Yang N; Mu W; Atkins RC
    Am J Pathol; 1997 Aug; 151(2):531-8. PubMed ID: 9250165
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevention and treatment of experimental crescentic glomerulonephritis by blocking tumour necrosis factor-alpha.
    Karkar AM; Smith J; Pusey CD
    Nephrol Dial Transplant; 2001 Mar; 16(3):518-24. PubMed ID: 11239025
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An inhibitor of spleen tyrosine kinase suppresses experimental crescentic glomerulonephritis.
    Han Y; Ma FY; Di Paolo J; Nikolic-Paterson DJ
    Int J Immunopathol Pharmacol; 2018; 32():2058738418783404. PubMed ID: 29923438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of activated periglomerular leukocytes in the rupture of Bowman's capsule and glomerular crescent progression in experimental glomerulonephritis.
    Lan HY; Nikolic-Paterson DJ; Atkins RC
    Lab Invest; 1992 Dec; 67(6):743-51. PubMed ID: 1460865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Glomerular expression of C-C chemokines in different types of human crescentic glomerulonephritis.
    Liu ZH; Chen SF; Zhou H; Chen HP; Li LS
    Nephrol Dial Transplant; 2003 Aug; 18(8):1526-34. PubMed ID: 12897090
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Apoptosis in progressive crescentic glomerulonephritis.
    Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N
    Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bezafibrate suppresses rat antiglomerular basement membrane crescentic glomerulonephritis.
    Saga D; Sakatsume M; Ogawa A; Tsubata Y; Kaneko Y; Kuroda T; Sato F; Ajiro J; Kondo D; Miida T; Narita I; Gejyo F
    Kidney Int; 2005 May; 67(5):1821-9. PubMed ID: 15840029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.